nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PGR—multiple sclerosis	0.19	0.593	CbGaD
Drospirenone—BCHE—multiple sclerosis	0.13	0.406	CbGaD
Drospirenone—NR3C2—Betamethasone—multiple sclerosis	0.0699	0.218	CbGbCtD
Drospirenone—NR3C2—Prednisolone—multiple sclerosis	0.069	0.215	CbGbCtD
Drospirenone—PGR—Betamethasone—multiple sclerosis	0.0451	0.141	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—multiple sclerosis	0.0407	0.127	CbGbCtD
Drospirenone—PGR—Dexamethasone—multiple sclerosis	0.0263	0.082	CbGbCtD
Drospirenone—BCHE—Triamcinolone—multiple sclerosis	0.0247	0.077	CbGbCtD
Drospirenone—PTGS2—Triamcinolone—multiple sclerosis	0.019	0.0592	CbGbCtD
Drospirenone—PTGS2—Betamethasone—multiple sclerosis	0.0163	0.0508	CbGbCtD
Drospirenone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.0155	0.0501	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.0151	0.0489	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—multiple sclerosis	0.0143	0.0464	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.0138	0.0447	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.0133	0.0431	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—multiple sclerosis	0.0131	0.0424	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—multiple sclerosis	0.0131	0.0424	CrCrCtD
Drospirenone—Medrysone—Prednisolone—multiple sclerosis	0.0127	0.0413	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.0121	0.0391	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—multiple sclerosis	0.0118	0.0384	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—multiple sclerosis	0.0117	0.0379	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—multiple sclerosis	0.0115	0.0373	CrCrCtD
Drospirenone—Testolactone—Betamethasone—multiple sclerosis	0.0115	0.0373	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—multiple sclerosis	0.0113	0.0365	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—multiple sclerosis	0.011	0.0357	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—multiple sclerosis	0.0107	0.0348	CrCrCtD
Drospirenone—Testolactone—Prednisone—multiple sclerosis	0.0107	0.0346	CrCrCtD
Drospirenone—Testolactone—Prednisolone—multiple sclerosis	0.0104	0.0338	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—multiple sclerosis	0.00947	0.0296	CbGbCtD
Drospirenone—Progesterone—Prednisolone—multiple sclerosis	0.00933	0.0303	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—multiple sclerosis	0.00932	0.0302	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—multiple sclerosis	0.0091	0.0295	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00854	0.0277	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00841	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00841	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00822	0.0266	CrCrCtD
Drospirenone—Testosterone—Prednisolone—multiple sclerosis	0.0081	0.0263	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—multiple sclerosis	0.0078	0.0253	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—multiple sclerosis	0.00761	0.0247	CrCrCtD
Drospirenone—Infarction—Cladribine—multiple sclerosis	0.00225	0.0692	CcSEcCtD
Drospirenone—Infarction—Methylprednisolone—multiple sclerosis	0.00112	0.0343	CcSEcCtD
Drospirenone—Thrombosis—Cladribine—multiple sclerosis	0.000884	0.0272	CcSEcCtD
Drospirenone—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.000818	0.0251	CcSEcCtD
Drospirenone—Migraine—Fingolimod—multiple sclerosis	0.000789	0.0242	CcSEcCtD
Drospirenone—Thromboembolic event—Methotrexate—multiple sclerosis	0.000761	0.0234	CcSEcCtD
Drospirenone—PTGS2—leg—multiple sclerosis	0.000676	0.125	CbGeAlD
Drospirenone—Embolism venous—Prednisolone—multiple sclerosis	0.000669	0.0205	CcSEcCtD
Drospirenone—Depression—Fingolimod—multiple sclerosis	0.000616	0.0189	CcSEcCtD
Drospirenone—Embolism venous—Triamcinolone—multiple sclerosis	0.000615	0.0189	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—multiple sclerosis	0.000614	0.0188	CcSEcCtD
Drospirenone—Embolism venous—Dexamethasone—multiple sclerosis	0.000558	0.0171	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—multiple sclerosis	0.000558	0.0171	CcSEcCtD
Drospirenone—Embolism—Prednisolone—multiple sclerosis	0.000526	0.0161	CcSEcCtD
Drospirenone—Angiopathy—Fingolimod—multiple sclerosis	0.000503	0.0154	CcSEcCtD
Drospirenone—Embolism venous—Prednisone—multiple sclerosis	0.000486	0.0149	CcSEcCtD
Drospirenone—Mental disorder—Fingolimod—multiple sclerosis	0.000486	0.0149	CcSEcCtD
Drospirenone—Embolism—Triamcinolone—multiple sclerosis	0.000483	0.0148	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—multiple sclerosis	0.000482	0.0148	CcSEcCtD
Drospirenone—Cerebrovascular accident—Cladribine—multiple sclerosis	0.000464	0.0142	CcSEcCtD
Drospirenone—Loss of libido—Methotrexate—multiple sclerosis	0.000444	0.0136	CcSEcCtD
Drospirenone—Embolism—Betamethasone—multiple sclerosis	0.000439	0.0135	CcSEcCtD
Drospirenone—Embolism—Dexamethasone—multiple sclerosis	0.000439	0.0135	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.000408	0.0125	CcSEcCtD
Drospirenone—Megestrol acetate—PGR—multiple sclerosis	0.000391	0.284	CrCbGaD
Drospirenone—Nervous system disorder—Fingolimod—multiple sclerosis	0.000386	0.0119	CcSEcCtD
Drospirenone—Skin disorder—Fingolimod—multiple sclerosis	0.000383	0.0117	CcSEcCtD
Drospirenone—Embolism—Prednisone—multiple sclerosis	0.000382	0.0117	CcSEcCtD
Drospirenone—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	0.000354	0.0358	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00034	0.0104	CcSEcCtD
Drospirenone—NR3C2—brainstem—multiple sclerosis	0.000339	0.063	CbGeAlD
Drospirenone—NR3C2—retina—multiple sclerosis	0.000328	0.0607	CbGeAlD
Drospirenone—Embolism—Methotrexate—multiple sclerosis	0.000319	0.0098	CcSEcCtD
Drospirenone—Haemoglobin—Cladribine—multiple sclerosis	0.000316	0.0097	CcSEcCtD
Drospirenone—Haemorrhage—Cladribine—multiple sclerosis	0.000314	0.00965	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.0003	0.0303	CbGpPWpGaD
Drospirenone—Erythema multiforme—Cladribine—multiple sclerosis	0.000297	0.00913	CcSEcCtD
Drospirenone—Angiopathy—Cladribine—multiple sclerosis	0.000285	0.00876	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.000277	0.028	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—VCAM1—multiple sclerosis	0.000276	0.0279	CbGpPWpGaD
Drospirenone—Mental disorder—Cladribine—multiple sclerosis	0.000275	0.00846	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	0.000269	0.0272	CbGpPWpGaD
Drospirenone—Haemoglobin—Azathioprine—multiple sclerosis	0.000257	0.00789	CcSEcCtD
Drospirenone—Haemorrhage—Azathioprine—multiple sclerosis	0.000256	0.00785	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000249	0.0251	CbGpPWpGaD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000247	0.159	CbGdCrCtD
Drospirenone—Spironolactone—PGR—multiple sclerosis	0.000243	0.176	CrCbGaD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000243	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000243	0.156	CbGdCrCtD
Drospirenone—Erythema multiforme—Azathioprine—multiple sclerosis	0.000242	0.00742	CcSEcCtD
Drospirenone—Affect lability—Prednisolone—multiple sclerosis	0.000241	0.0074	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000237	0.153	CbGdCrCtD
Drospirenone—NR3C2—medulla oblongata—multiple sclerosis	0.000237	0.0439	CbGeAlD
Drospirenone—Mood swings—Prednisolone—multiple sclerosis	0.000232	0.00713	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000231	0.0071	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.000228	0.165	CrCbGaD
Drospirenone—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000227	0.00697	CcSEcCtD
Drospirenone—Norethindrone—PGR—multiple sclerosis	0.000226	0.164	CrCbGaD
Drospirenone—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000226	0.00693	CcSEcCtD
Drospirenone—Affect lability—Triamcinolone—multiple sclerosis	0.000222	0.00681	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—multiple sclerosis	0.000221	0.00679	CcSEcCtD
Drospirenone—Nervous system disorder—Cladribine—multiple sclerosis	0.000219	0.00672	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.000219	0.0221	CbGpPWpGaD
Drospirenone—Skin disorder—Cladribine—multiple sclerosis	0.000217	0.00666	CcSEcCtD
Drospirenone—NR3C2—midbrain—multiple sclerosis	0.000216	0.0401	CbGeAlD
Drospirenone—Mood swings—Triamcinolone—multiple sclerosis	0.000213	0.00655	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—multiple sclerosis	0.000213	0.00654	CcSEcCtD
Drospirenone—NR3C2—spinal cord—multiple sclerosis	0.000211	0.0391	CbGeAlD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00021	0.0212	CbGpPWpGaD
Drospirenone—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000208	0.00638	CcSEcCtD
Drospirenone—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000207	0.00634	CcSEcCtD
Drospirenone—BCHE—brainstem—multiple sclerosis	0.000205	0.0379	CbGeAlD
Drospirenone—Breast disorder—Methylprednisolone—multiple sclerosis	0.000203	0.00624	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—multiple sclerosis	0.000201	0.00618	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—multiple sclerosis	0.000201	0.00618	CcSEcCtD
Drospirenone—Migraine—Betamethasone—multiple sclerosis	0.000201	0.00618	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—multiple sclerosis	0.000201	0.00618	CcSEcCtD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.0002	0.0202	CbGpPWpGaD
Drospirenone—Mood swings—Betamethasone—multiple sclerosis	0.000194	0.00595	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—multiple sclerosis	0.000194	0.00595	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000193	0.00592	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000188	0.00578	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000186	0.00572	CcSEcCtD
Drospirenone—PGR—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000185	0.0187	CbGpPWpGaD
Drospirenone—Myocardial infarction—Prednisolone—multiple sclerosis	0.000185	0.00568	CcSEcCtD
Drospirenone—NR3C2—nervous system—multiple sclerosis	0.000178	0.033	CbGeAlD
Drospirenone—Skin disorder—Azathioprine—multiple sclerosis	0.000176	0.00542	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—PGR—multiple sclerosis	0.000176	0.0178	CbGpPWpGaD
Drospirenone—Affect lability—Prednisone—multiple sclerosis	0.000175	0.00538	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	0.000174	0.0175	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000172	0.0173	CbGpPWpGaD
Drospirenone—NR3C2—central nervous system—multiple sclerosis	0.000171	0.0318	CbGeAlD
Drospirenone—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000171	0.00526	CcSEcCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000171	0.00524	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—multiple sclerosis	0.00017	0.00523	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00017	0.00523	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00017	0.00521	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—multiple sclerosis	0.000169	0.0052	CcSEcCtD
Drospirenone—Mood swings—Prednisone—multiple sclerosis	0.000169	0.00518	CcSEcCtD
Drospirenone—NR3C2—cerebellum—multiple sclerosis	0.000167	0.031	CbGeAlD
Drospirenone—PGR—nervous system—multiple sclerosis	0.000165	0.0307	CbGeAlD
Drospirenone—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.000162	0.0164	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—VDR—multiple sclerosis	0.000161	0.0163	CbGpPWpGaD
Drospirenone—PGR—central nervous system—multiple sclerosis	0.000159	0.0295	CbGeAlD
Drospirenone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000157	0.00481	CcSEcCtD
Drospirenone—Haemoglobin—Triamcinolone—multiple sclerosis	0.000157	0.00481	CcSEcCtD
Drospirenone—AR—spinal cord—multiple sclerosis	0.000156	0.029	CbGeAlD
Drospirenone—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000156	0.0048	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—multiple sclerosis	0.000156	0.00479	CcSEcCtD
Drospirenone—PGR—cerebellum—multiple sclerosis	0.000156	0.0289	CbGeAlD
Drospirenone—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000156	0.00478	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000155	0.00477	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000155	0.00477	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—multiple sclerosis	0.000154	0.00474	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000154	0.00474	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000152	0.00466	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000149	0.0958	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000146	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000146	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000143	0.0921	CbGdCrCtD
Drospirenone—BCHE—medulla oblongata—multiple sclerosis	0.000143	0.0265	CbGeAlD
Drospirenone—Skin disorder—Mitoxantrone—multiple sclerosis	0.000143	0.00438	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—multiple sclerosis	0.000142	0.00436	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—multiple sclerosis	0.000142	0.00436	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—multiple sclerosis	0.000141	0.00434	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—multiple sclerosis	0.000141	0.00434	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—multiple sclerosis	0.000141	0.00433	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—multiple sclerosis	0.000141	0.00433	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000139	0.0141	CbGpPWpGaD
Drospirenone—Depression—Prednisone—multiple sclerosis	0.000137	0.0042	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—multiple sclerosis	0.000136	0.00418	CcSEcCtD
Drospirenone—NR3C2—brain—multiple sclerosis	0.000136	0.0252	CbGeAlD
Drospirenone—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000135	0.00415	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—multiple sclerosis	0.000134	0.00413	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.000134	0.0136	CbGpPWpGaD
Drospirenone—Breast disorder—Methotrexate—multiple sclerosis	0.000134	0.00413	CcSEcCtD
Drospirenone—Nausea—Cladribine—multiple sclerosis	0.000133	0.00407	CcSEcCtD
Drospirenone—AR—nervous system—multiple sclerosis	0.000132	0.0244	CbGeAlD
Drospirenone—Progesterone—PGR—multiple sclerosis	0.000132	0.0955	CrCbGaD
Drospirenone—BCHE—midbrain—multiple sclerosis	0.00013	0.0242	CbGeAlD
Drospirenone—Angiopathy—Betamethasone—multiple sclerosis	0.000128	0.00394	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—multiple sclerosis	0.000128	0.00394	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000128	0.0129	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL1B—multiple sclerosis	0.000128	0.0129	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	0.000127	0.0129	CbGpPWpGaD
Drospirenone—BCHE—spinal cord—multiple sclerosis	0.000127	0.0236	CbGeAlD
Drospirenone—AR—central nervous system—multiple sclerosis	0.000127	0.0235	CbGeAlD
Drospirenone—PGR—brain—multiple sclerosis	0.000126	0.0234	CbGeAlD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000124	0.0126	CbGpPWpGaD
Drospirenone—Haemoglobin—Prednisone—multiple sclerosis	0.000124	0.0038	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—multiple sclerosis	0.000123	0.00378	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—VDR—multiple sclerosis	0.000123	0.0124	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000114	0.00351	CcSEcCtD
Drospirenone—Depression—Methotrexate—multiple sclerosis	0.000114	0.00351	CcSEcCtD
Drospirenone—Angiopathy—Prednisone—multiple sclerosis	0.000112	0.00343	CcSEcCtD
Drospirenone—PTGS2—medulla oblongata—multiple sclerosis	0.00011	0.0204	CbGeAlD
Drospirenone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000108	0.00333	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—multiple sclerosis	0.000108	0.00331	CcSEcCtD
Drospirenone—Nausea—Azathioprine—multiple sclerosis	0.000108	0.00331	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000107	0.0033	CcSEcCtD
Drospirenone—BCHE—nervous system—multiple sclerosis	0.000107	0.0199	CbGeAlD
Drospirenone—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000106	0.0107	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000105	0.0106	CbGpPWpGaD
Drospirenone—Haemoglobin—Methotrexate—multiple sclerosis	0.000103	0.00318	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000103	0.0104	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.000103	0.0104	CbGpPWpGaD
Drospirenone—BCHE—central nervous system—multiple sclerosis	0.000103	0.0191	CbGeAlD
Drospirenone—Haemorrhage—Methotrexate—multiple sclerosis	0.000103	0.00316	CcSEcCtD
Drospirenone—BCHE—cerebellum—multiple sclerosis	0.000101	0.0187	CbGeAlD
Drospirenone—AR—brain—multiple sclerosis	0.000101	0.0187	CbGeAlD
Drospirenone—PTGS2—midbrain—multiple sclerosis	0.0001	0.0186	CbGeAlD
Drospirenone—BCHE—Neuronal System—KCNA3—multiple sclerosis	9.89e-05	0.01	CbGpPWpGaD
Drospirenone—Nervous system disorder—Dexamethasone—multiple sclerosis	9.85e-05	0.00303	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—multiple sclerosis	9.85e-05	0.00303	CcSEcCtD
Drospirenone—PTGS2—spinal cord—multiple sclerosis	9.8e-05	0.0182	CbGeAlD
Drospirenone—Erythema multiforme—Methotrexate—multiple sclerosis	9.73e-05	0.00299	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	9.72e-05	0.00983	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—MAPK1—multiple sclerosis	9.72e-05	0.00983	CbGpPWpGaD
Drospirenone—Angiopathy—Methotrexate—multiple sclerosis	9.34e-05	0.00287	CcSEcCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—multiple sclerosis	9.26e-05	0.00936	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.06e-05	0.00278	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—multiple sclerosis	9.02e-05	0.00277	CcSEcCtD
Drospirenone—Nausea—Mitoxantrone—multiple sclerosis	8.72e-05	0.00268	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	8.67e-05	0.00266	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	8.67e-05	0.00266	CcSEcCtD
Drospirenone—Nervous system disorder—Prednisone—multiple sclerosis	8.58e-05	0.00263	CcSEcCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	8.54e-05	0.00863	CbGpPWpGaD
Drospirenone—Skin disorder—Prednisone—multiple sclerosis	8.5e-05	0.00261	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	8.46e-05	0.00855	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	8.31e-05	0.0084	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ZNF746—multiple sclerosis	8.26e-05	0.00835	CbGpPWpGaD
Drospirenone—PTGS2—nervous system—multiple sclerosis	8.26e-05	0.0153	CbGeAlD
Drospirenone—BCHE—brain—multiple sclerosis	8.19e-05	0.0152	CbGeAlD
Drospirenone—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	7.96e-05	0.00805	CbGpPWpGaD
Drospirenone—PTGS2—central nervous system—multiple sclerosis	7.95e-05	0.0147	CbGeAlD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.83e-05	0.00791	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	7.83e-05	0.00791	CbGpPWpGaD
Drospirenone—PTGS2—cerebellum—multiple sclerosis	7.77e-05	0.0144	CbGeAlD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	7.61e-05	0.00769	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	7.58e-05	0.00233	CcSEcCtD
Drospirenone—NR3C2—Gene Expression—PTBP1—multiple sclerosis	7.56e-05	0.00764	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	7.43e-05	0.0075	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CD28—multiple sclerosis	7.4e-05	0.00748	CbGpPWpGaD
Drospirenone—Nervous system disorder—Methotrexate—multiple sclerosis	7.17e-05	0.0022	CcSEcCtD
Drospirenone—Nausea—Prednisolone—multiple sclerosis	7.15e-05	0.0022	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	7.1e-05	0.00718	CbGpPWpGaD
Drospirenone—Skin disorder—Methotrexate—multiple sclerosis	7.1e-05	0.00218	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	6.71e-05	0.00679	CbGpPWpGaD
Drospirenone—Nausea—Triamcinolone—multiple sclerosis	6.58e-05	0.00202	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—multiple sclerosis	6.56e-05	0.00202	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	6.53e-05	0.0066	CbGpPWpGaD
Drospirenone—Norethindrone—ALB—multiple sclerosis	6.35e-05	0.0461	CrCbGaD
Drospirenone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.31e-05	0.00194	CcSEcCtD
Drospirenone—PTGS2—brain—multiple sclerosis	6.31e-05	0.0117	CbGeAlD
Drospirenone—Methyltestosterone—ALB—multiple sclerosis	6.03e-05	0.0437	CrCbGaD
Drospirenone—Nausea—Dexamethasone—multiple sclerosis	5.97e-05	0.00183	CcSEcCtD
Drospirenone—Nausea—Betamethasone—multiple sclerosis	5.97e-05	0.00183	CcSEcCtD
Drospirenone—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	5.73e-05	0.00579	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—U2AF2—multiple sclerosis	5.73e-05	0.00579	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—HNRNPA1—multiple sclerosis	5.73e-05	0.00579	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	5.63e-05	0.00569	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	5.63e-05	0.00569	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	5.52e-05	0.00558	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	5.37e-05	0.00543	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CD86—multiple sclerosis	5.28e-05	0.00534	CbGpPWpGaD
Drospirenone—Nausea—Prednisone—multiple sclerosis	5.2e-05	0.0016	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—PGR—multiple sclerosis	5.18e-05	0.00523	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ZNF746—multiple sclerosis	5.03e-05	0.00509	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	5.02e-05	0.00508	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	4.92e-05	0.00498	CbGpPWpGaD
Drospirenone—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	4.79e-05	0.00484	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PTBP1—multiple sclerosis	4.6e-05	0.00465	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	4.56e-05	0.00461	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	4.53e-05	0.00458	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.5e-05	0.00455	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	4.46e-05	0.00451	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	4.44e-05	0.00449	CbGpPWpGaD
Drospirenone—Nausea—Methotrexate—multiple sclerosis	4.34e-05	0.00133	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.29e-05	0.00434	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	4.23e-05	0.00427	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	4.05e-05	0.00409	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	3.9e-05	0.00394	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.87e-05	0.00391	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CD80—multiple sclerosis	3.85e-05	0.0039	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ZNF746—multiple sclerosis	3.83e-05	0.00388	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—POMC—multiple sclerosis	3.71e-05	0.00375	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	3.68e-05	0.00372	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	3.62e-05	0.00366	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.6e-05	0.00364	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.6e-05	0.00364	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PABPC1—multiple sclerosis	3.51e-05	0.00355	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PTBP1—multiple sclerosis	3.51e-05	0.00354	CbGpPWpGaD
Drospirenone—Testosterone—ALB—multiple sclerosis	3.5e-05	0.0254	CrCbGaD
Drospirenone—PGR—Gene Expression—U2AF2—multiple sclerosis	3.49e-05	0.00353	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HNRNPA1—multiple sclerosis	3.49e-05	0.00353	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.44e-05	0.00348	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	3.26e-05	0.0033	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	3.25e-05	0.00329	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	3.25e-05	0.00328	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	3.24e-05	0.00328	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—RPL5—multiple sclerosis	3.17e-05	0.0032	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.95e-05	0.00298	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	2.91e-05	0.00294	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	2.89e-05	0.00292	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ZFP36L1—multiple sclerosis	2.76e-05	0.00279	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.72e-05	0.00274	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	2.7e-05	0.00273	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	2.7e-05	0.00272	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.67e-05	0.0027	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	2.66e-05	0.00269	CbGpPWpGaD
Drospirenone—AR—Gene Expression—U2AF2—multiple sclerosis	2.66e-05	0.00269	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HNRNPA1—multiple sclerosis	2.66e-05	0.00269	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LINGO1—multiple sclerosis	2.62e-05	0.00264	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	2.54e-05	0.00257	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PGR—multiple sclerosis	2.49e-05	0.00252	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.48e-05	0.00251	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.48e-05	0.00251	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.47e-05	0.00249	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.43e-05	0.00246	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.41e-05	0.00244	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	2.4e-05	0.00243	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.36e-05	0.00239	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SRM—multiple sclerosis	2.28e-05	0.0023	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TAGAP—multiple sclerosis	2.27e-05	0.00229	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	2.26e-05	0.00229	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.25e-05	0.00227	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	2.24e-05	0.00226	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	2.2e-05	0.00223	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	2.15e-05	0.00217	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PABPC1—multiple sclerosis	2.14e-05	0.00216	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	2.1e-05	0.00212	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ZFP36L1—multiple sclerosis	2.1e-05	0.00212	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	2.07e-05	0.00209	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	2.07e-05	0.00209	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.07e-05	0.00209	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	2.05e-05	0.00208	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.03e-05	0.00205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—S1PR1—multiple sclerosis	1.98e-05	0.002	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.98e-05	0.002	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—RPL5—multiple sclerosis	1.93e-05	0.00195	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GPC5—multiple sclerosis	1.93e-05	0.00195	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	1.92e-05	0.00194	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	1.85e-05	0.00187	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.84e-05	0.00186	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—VDR—multiple sclerosis	1.74e-05	0.00176	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.69e-05	0.00171	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RGS1—multiple sclerosis	1.69e-05	0.0017	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	1.68e-05	0.0017	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	1.63e-05	0.00165	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PABPC1—multiple sclerosis	1.63e-05	0.00165	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.62e-05	0.00164	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP24A1—multiple sclerosis	1.6e-05	0.00162	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP27B1—multiple sclerosis	1.6e-05	0.00162	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.6e-05	0.00162	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.59e-05	0.00161	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.59e-05	0.0016	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SRM—multiple sclerosis	1.57e-05	0.00158	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.49e-05	0.00151	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.47e-05	0.00149	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RPL5—multiple sclerosis	1.47e-05	0.00149	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GPC5—multiple sclerosis	1.47e-05	0.00148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL13—multiple sclerosis	1.46e-05	0.00148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR1—multiple sclerosis	1.46e-05	0.00148	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.46e-05	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.45e-05	0.00147	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	1.44e-05	0.00145	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.37e-05	0.00139	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.34e-05	0.00136	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.34e-05	0.00135	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.34e-05	0.00135	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.31e-05	0.00133	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.25e-05	0.00126	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RRM1—multiple sclerosis	1.22e-05	0.00123	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GPC5—multiple sclerosis	1.21e-05	0.00122	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.19e-05	0.0012	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PGR—multiple sclerosis	1.16e-05	0.00117	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.14e-05	0.00115	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.13e-05	0.00114	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.11e-05	0.00112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.1e-05	0.00112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.1e-05	0.00112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.08e-05	0.00109	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.08e-05	0.00109	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—multiple sclerosis	1.06e-05	0.00107	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.06e-05	0.00107	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.06e-05	0.00107	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL3—multiple sclerosis	1.04e-05	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPC5—multiple sclerosis	1.01e-05	0.00102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTGER4—multiple sclerosis	1e-05	0.00101	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR3—multiple sclerosis	9.68e-06	0.000979	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD28—multiple sclerosis	9.59e-06	0.000969	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.44e-06	0.000954	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR2—multiple sclerosis	9.42e-06	0.000952	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	8.76e-06	0.000885	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CNR1—multiple sclerosis	8.69e-06	0.000879	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	8.54e-06	0.000863	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RRM1—multiple sclerosis	8.37e-06	0.000846	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—MAPK1—multiple sclerosis	8.11e-06	0.000819	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.11e-06	0.000819	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—multiple sclerosis	8.08e-06	0.000817	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPL5—multiple sclerosis	7.84e-06	0.000793	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL10—multiple sclerosis	7.83e-06	0.000791	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.72e-06	0.000781	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.71e-06	0.000779	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.56e-06	0.000764	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC11A1—multiple sclerosis	7.51e-06	0.000759	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.39e-06	0.000747	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.2e-06	0.000727	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—multiple sclerosis	7.01e-06	0.000708	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—multiple sclerosis	6.92e-06	0.0007	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	6.85e-06	0.000693	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD86—multiple sclerosis	6.84e-06	0.000692	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL5—multiple sclerosis	6.74e-06	0.000681	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	6.67e-06	0.000675	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.5e-06	0.000657	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—multiple sclerosis	6.24e-06	0.000631	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—multiple sclerosis	6.07e-06	0.000613	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD28—multiple sclerosis	6e-06	0.000606	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2RA—multiple sclerosis	5.98e-06	0.000605	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.58e-06	0.000564	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—multiple sclerosis	5.52e-06	0.000558	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.09e-06	0.000514	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD80—multiple sclerosis	4.99e-06	0.000505	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BCHE—multiple sclerosis	4.81e-06	0.000486	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—multiple sclerosis	4.74e-06	0.000479	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—multiple sclerosis	4.64e-06	0.000469	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD86—multiple sclerosis	4.28e-06	0.000433	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—multiple sclerosis	4.22e-06	0.000426	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TYK2—multiple sclerosis	4.21e-06	0.000426	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—multiple sclerosis	4.2e-06	0.000425	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—multiple sclerosis	3.8e-06	0.000384	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HLA-A—multiple sclerosis	3.7e-06	0.000374	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—multiple sclerosis	3.61e-06	0.000365	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—multiple sclerosis	3.51e-06	0.000354	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—multiple sclerosis	3.45e-06	0.000349	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—multiple sclerosis	3.32e-06	0.000335	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—multiple sclerosis	3.29e-06	0.000333	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—multiple sclerosis	3.21e-06	0.000325	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD80—multiple sclerosis	3.12e-06	0.000316	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—multiple sclerosis	2.95e-06	0.000298	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—multiple sclerosis	2.89e-06	0.000292	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—multiple sclerosis	2.74e-06	0.000277	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—multiple sclerosis	2.74e-06	0.000276	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK1—multiple sclerosis	2.68e-06	0.000271	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TYK2—multiple sclerosis	2.64e-06	0.000266	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—multiple sclerosis	2.49e-06	0.000251	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—multiple sclerosis	2.38e-06	0.000241	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—multiple sclerosis	2.27e-06	0.000229	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—multiple sclerosis	2.06e-06	0.000208	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—multiple sclerosis	1.85e-06	0.000187	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—multiple sclerosis	1.72e-06	0.000173	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—multiple sclerosis	1.71e-06	0.000173	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK1—multiple sclerosis	1.68e-06	0.00017	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—multiple sclerosis	1.29e-06	0.00013	CbGpPWpGaD
